Table 1 Baseline characteristics before and after matching cohorts
From: Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis
Characteristics | No. (%) before PSM | No. (%) after PSM | ||||||
|---|---|---|---|---|---|---|---|---|
Total | Men (N = 133) | Women (N = 167) | p value | Total | Men (N = 101) | Women (N = 101) | p value | |
Age (mean± SD), years | 65.3 ± 14.6 | 65.6 ± 14.6 | 65.0 ± 14.7 | 0.74 | 65.3 ± 14.8 | 65.2 ± 14.9 | 65.4 ± 14.7 | 0.92 |
Age ≥ 65 | 148 (49.3) | 78 (58.6) | 70 (41.9) | 0.004* | 83 (41.1) | 41 (40.6) | 42 (41.6) | 0.89 |
Age < 65 | 152 (50.7) | 55 (41.4) | 97 (58.1) | 119 (58.9) | 60 (59.4) | 59 (58.4) | ||
BMI | ||||||||
Under and normal weight | 220 (73.3) | 93 (69.9) | 127 (76.0) | 0.47 | 146 (72.2) | 71 (70.3) | 75 (74.2) | 0.3 |
Overweight | 69 (23.0) | 35 (26.3) | 34 (20.4) | 49 (24.3) | 28 (27.7) | 21 (20.8) | ||
Obese | 11 (3.7) | 5 (3.8) | 6 (3.6) | 7 (3.5) | 2 (2.0) | 5 (5.0) | ||
Comorbidities | ||||||||
Hypertension | 196 (65.3) | 94 (70.7) | 102 (61.1) | 0.08 | 130 (64.4) | 66 (65.3) | 64 (63.4) | 0.77 |
Diabetes | 57 (19.0) | 26 (19.5) | 31 (18.6) | 0.83 | 37 (18.3) | 21 (3.6) | 16 (3.6) | 0.36 |
Cancer | 8 (26.7) | 5 (3.8) | 3 (1.8) | 0.29 | 3 (1.5) | 2 (20.8) | 1 (1.0) | 0.56 |
Coronary heart disease | 57 (19.0) | 24 (18.0) | 33 (19.8) | 0.71 | 39 (19.3) | 18 (17.8) | 21 (20.8) | 0.59 |
COPD | 39 (13.0) | 24 (61.5) | 15 (38.5) | 0.02* | 22 (10.9) | 12 (11.9) | 10 (10.0) | 0.65 |
Cerebrovascular disease | 30 (10.0) | 14 (46.7) | 16 (53.3) | 0.79 | 25 (12.4) | 11 (10.0) | 14 (13.9) | 0.52 |
Treated with corticosteroids | ||||||||
Yes | 19 (6.3) | 13 (9.8) | 6 (3.6) | 0.03* | 9 (4.5) | 3 (3.0) | 6 (5.9) | 0.31 |
No | 281 (93.7) | 120 (90.2) | 161 (96.4) | 193 (95.5) | 98 (97.0) | 95(94.1) | ||
Treated with interferon | ||||||||
Yes | 35 (11.7) | 16 (12.0) | 19 (11.4) | 0.86 | 176 (87.1) | 88 (87.1) | 88 (87.1) | 1 |
No | 265 (88.3) | 117 (88.0) | 148 (88.6) | 26 (12.9) | 13 (12.9) | 13 (12.9) | ||
Treated with arbidol | ||||||||
Yes | 153 (51.0) | 77 (57.9) | 76 (45.5) | 0.03* | 101 (50.0) | 49 (48.5) | 52 (51.5) | 0.67 |
No | 147 (49.0) | 56 (42.1) | 91 (54.5) | 101 (50.0) | 52 (51.5) | 49 (48.5) | ||
Lactic dehydrogenase | ||||||||
Abnormal | 38 (12.7) | 20 (15.0) | 18 (10.8) | 0.27 | 180 (89.1) | 91 (90.1) | 89 (88.1) | 0.65 |
Normal | 262 (87.3) | 113 (85.0) | 149 (89.2) | 22 (10.9) | 10 (9.9) | 12 (11.9) | ||
Lymphocyte | ||||||||
Abnormal | 207 (69.0) | 81 (60.9) | 126 (75.4) | 0.007* | 61 (30.2) | 29 (28.7) | 32 (31.7) | 0.65 |
Normal | 93 (31.0) | 52 (39.1) | 41 (24.6) | 141 (69.8) | 72 (71.3) | 69 (68.3) | ||
C-reaction protein | ||||||||
Abnormal | 70 (23.3) | 41 (30.8) | 29 (17.4) | 0.006* | 161 (79.7) | 80 (79.2) | 81 (80.2) | 0.86 |
Normal | 230 (76.7) | 92 (69.2) | 138 (82.6) | 41 (20.3) | 21 (20.8) | 20 (19.8) | ||